Captrust Financial Advisors Agenus Inc Transaction History

Captrust Financial Advisors

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.63 - $1.14 $227,063 - $410,877	-360,419 Reduced 65.58%	189,193 $157,000
Q3 2023 Nov 14, 2023	SELL	$1.12 - $1.88 $147,006 - $246,761	-131,256 Reduced 19.28%	549,612 $621,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $16,762 - $26,103	12,796 Added 1.92%	680,868 $1.09 Million
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $49,458 - $100,621	34,109 Added 5.38%	668,072 $1.02 Million
Q4 2022 Feb 15, 2023	BUY	$2.02 - $3.25 $40,947 - $65,880	20,271 Added 3.3%	633,963 $1.52 Million
Q2 2022 Aug 16, 2022	BUY	$1.3 - $2.64 $85,599 - $173,833	65,846 Added 12.02%	613,692 $1.19 Million
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $12,111 - $17,884	5,154 Added 0.95%	547,846 $1.35 Million
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $4,964 - $9,758	1,700 Added 0.31%	542,692 $1.75 Million
Q3 2021 Nov 16, 2021	BUY	$4.98 - $6.63 $36,712 - $48,876	7,372 Added 1.38%	540,992 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $4,167 - $8,937	1,628 Added 0.31%	533,620 $2.93 Million
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $53,800 - $105,000	20,000 Added 3.91%	531,992 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$3.17 - $4.49 $49,388 - $69,954	15,580 Added 3.14%	511,992 $1.63 Million
Q3 2020 Nov 17, 2020	BUY	$2.98 - $5.2 $59,600 - $104,000	20,000 Added 4.2%	496,412 $2.01 Million
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $174,528 - $399,051	90,900 Added 23.58%	476,412 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $929,083 - $1.7 Million	385,512 New	385,512 $1.56 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.